Clik here to view.
Dr. Januario E. Castro Receives R01 Grant Award for Leukemia Research
Januario E. Castro, M.D., has received a 3-year R01 grant from the Food and Drug Administration to investigate a new immunogene therapy for chronic lymphocytic leukemia (CLL). Dr. Castro is Assistant...
View ArticleClik here to view.
Cancer Center Evaluating New Treatment for Chronic Lymphocytic Leukemia
Moores UCSD Cancer Center investigators have begun a clinical trial of a new treatment for chronic lymphocytic leukemia. The study, a Phase I safety trial, is enrolling selected patients whose leukemia...
View ArticleClik here to view.
In the Media: Dr. Januario Castro
Dr. Januario Castro’s investigations of a new immunotherapeutic agent for chronic lymphocytic leukemia are the subject of the story, “Leukaemia Treatment Can Be A Shot Away” on BiomedME.com. Januario...
View ArticleClik here to view.
UCSD-based Cancer Consortium Receives 5-Year, $20 Million Grant Renewal
NCI funding continues work focused on chronic lymphocytic leukemia An international consortium of scientists studying chronic lymphocytic leukemia (CLL), based at the University of California, San...
View ArticleClik here to view.
Monoclonal Antibody Targets, Kills Leukemia Cells
Researchers at the University of California, San Diego Moores Cancer Center have identified a humanized monoclonal antibody that targets and directly kills chronic lymphocytic leukemia (CLL) cells…....
View ArticleClik here to view.
UC San Diego Researcher Receives $6.25 Million Grant
The Leukemia & Lymphoma Society has awarded Thomas J. Kipps, MD, PhD, Distinguished Professor of Medicine at the University of California, San Diego School of Medicine, with a 5-year, $6.25 million...
View ArticleClik here to view.
Novel Drug Targeting Leukemia Cells Enters Clinical Trial
Researchers at the University of California, San Diego School of Medicine have launched a phase 1 human clinical trial to assess the safety and efficacy of a new monoclonal antibody for patients with...
View ArticleClik here to view.
Anti-Leukemia Drug May Also Work Against Ovarian Cancer
An antibody therapy already in clinical trials to treat chronic lymphocytic leukemia (CLL) may also prove effective against ovarian cancer – and likely other cancers as well, report researchers at the...
View ArticleClik here to view.
UC San Diego Named Stem Cell “Alpha Clinic”
Designation will help speed development of emerging drugs and therapies — In a push to further speed clinical development of emerging stem cell therapies, Sanford Stem Cell Clinical Center at UC San...
View ArticleClik here to view.
Protein-Protein Interaction Activates and Fuels Leukemia Cell Growth
December 21, 2015 Findings also show how an experimental monoclonal antibody treatment inhibits growth and spread of cancer — Building upon previous research, scientists at University of California,...
View Article
